Partial complement factor H deficiency associates with C3 glomerulopathy and thrombotic microangiopathy

Journal of the American Society of Nephrology

Volumn 27, Issue 5, 2016, Pages 1334-1342

  Vernon, Katherine A ^a   Ruseva, Marieta M ^a   Cook, H Terence ^a   Botto, Marina ^a   Malik, Talat H ^a   Pickering, Matthew C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; COMPLEMENT C3 GLOMERULOPATHY; COMPLEMENT DEFICIENCY; COMPLEMENT FACTOR H DEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; IMMUNE COMPLEX NEPHRITIS; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANIMAL; ATYPICAL HEMOLYTIC UREMIC SYNDROME; COMPLICATION; DEFICIENCY; GLOMERULUS; KIDNEY; KIDNEY DISEASES; THROMBOTIC MICROANGIOPATHIES; VASCULARIZATION;

ANIMALS; ATYPICAL HEMOLYTIC UREMIC SYNDROME; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT FACTOR H; FEMALE; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MICE; THROMBOTIC MICROANGIOPATHIES;

EID: 85003581777     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015030295     Document Type: Article

References (32)

1. Barbour TD, RusevaMM, PickeringMC: Update on C3 glomerulopathy [published online ahead of print October 17, 2014]. Nephrol Dial Transplant doi: 10.1093/ndt/gfu317
2. Le Quintrec M, Roumenina L, Noris M, Frémeaux-Bacchi V: Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes. Semin Thromb Hemost 36: 641-652, 2010
3. Pickering MC, Cook HT: Translational mini-review series on complement factor H: Renal diseases associated with complement factor H: Novel insights from humans and animals. Clin Exp Immunol 151: 210-230, 2008
4. PickeringMC,D'Agati VD, NesterCM, Smith RJ,Haas M, AppelGB, Alpers CE, Bajema IM, Bedrosian C,BraunM,DoyleM, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E,GriffinG, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT: C3 glomerulopathy: Consensus report. Kidney Int 84: 1079-1089, 2013
5. Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD: Toward a working definition of C3 glomerulopathy by immunofluorescence. Kidney Int 85: 450-456, 2014
6. de Córdoba SR, de Jorge EG: Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H. Clin Exp Immunol 151: 1-13, 2008
7. Høgasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M: Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 95: 1054-1061, 1995
8. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31: 424-428, 2002
9. de Jorge EG, Macor P, Paixão-Cavalcante D, Rose KL, Tedesco F, Cook HT, Botto M, Pickering MC: The development of atypical hemolytic uremic syndrome depends on complement C5. J Am Soc Nephrol 22: 137-145, 2011
10. Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, Cook HT, Botto M: Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A 103: 9649-9654, 2006
11. Alexander JJ, Wang Y, Chang A, Jacob A, Minto AW, Karmegam M, Haas M, Quigg RJ: Mouse podocyte complement factor H: The functional analog to human complement receptor 1. J AmSocNephrol 18: 1157-1166, 2007
12. Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, Rose KL, Moss J, Walport MJ, Cook HT, de Córdoba SR, Botto M: Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J ExpMed 204: 1249-1256, 2007
13. Liu P, Jenkins NA, Copeland NG: A highly efficient recombineeringbased method for generating conditional knockout mutations. Genome Res 13: 476-484, 2003
14. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315, 1999
15. Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F: Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44: 193-199, 2007
16. West CD, Witte DP, McAdams AJ: Composition of nephritic factorgenerated glomerular deposits in membranoproliferative glomerulonephritis type 2. AmJ Kidney Dis 37: 1120-1130, 2001
17. Paixão-Cavalcante D, Hanson S, Botto M, Cook HT, Pickering MC: Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. Mol Immunol 46: 1942-1950, 2009
18. Lenderink AM, Liegel K, Ljubanovic D, Coleman KE, Gilkeson GS, Holers VM, Thurman JM: The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am J Physiol Renal Physiol 293: F555-F564, 2007
19. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC: Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376: 794-801, 2010
20. Vernon KA, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC: Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60: 121-125, 2012
21. Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, ZavrosM, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C: Familial C3 glomerulopathy associated with CFHR5 mutations: Clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol 6: 1436-1446, 2011
22. Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M; International Registry of Recurrent and Familial HUS/TTP: Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 12: 3385-3395, 2003
23. Vaziri-Sani F, Holmberg L, Sjöholm AG, Kristoffersson AC, Manea M, Frémeaux-Bacchi V, Fehrman-Ekholm I, Raafat R, Karpman D: Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 69: 981-988, 2006
24. Lorcy N, Rioux-Leclercq N, Lombard ML, Le Pogamp P, Vigneau C: Three kidneys, two diseases, one antibody? Nephrol Dial Transplant 26: 3811-3813, 2011
25. Brackman D, Sartz L, Leh S, Kristoffersson AC, Bjerre A, Tati R, Frémeaux-Bacchi V, Karpman D: Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis. Nephrol Dial Transplant 26: 3399-3403, 2011
26. Gnappi E, AllinoviM, Vaglio A, Bresin E, Sorosina A, Pilato FP, Allegri L, Manenti L: Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: Report of a case. Pediatr Nephrol 27: 1995-1999, 2012
27. Manenti L, Gnappi E, Vaglio A, Allegri L, Noris M, Bresin E, Pilato FP, Valoti E, Pasquali S, Buzio C: Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant 28: 2246-2259, 2013
28. Boyer O, Noël LH, Balzamo E, Guest G, Biebuyck N, Charbit M, Salomon R, Frémeaux-Bacchi V, Niaudet P: Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits. Am J Kidney Dis 51: 671-677, 2008
29. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, Martin DI, Enver T, Ley TJ, GroudineM: Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev 9: 2203-2213, 1995
30. Rose KL, Paixao-Cavalcante D, Fish J, Manderson AP, Malik TH, Bygrave AE, Lin T, Sacks SH,Walport MJ, Cook HT, Botto M, Pickering MC: Factor I is required for the development ofmembranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest 118: 608-618, 2008
31. Ruseva MM, Vernon KA, Lesher AM, Schwaeble WJ, Ali YM, Botto M, Cook T, Song W, Stover CM, Pickering MC: Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. J Am Soc Nephrol 24: 43-52, 2013
32. Robson MG, Cook HT, Botto M, Taylor PR, Busso N, Salvi R, Pusey CD, Walport MJ, Davies KA: Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol 166: 6820-6828, 2001